Skip to main content

Table 4 Changes in the main clinical and biological parameters between month 0 and month 24

From: Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice

Variable

Group

Month 0 Mean (SD)

Month 24 Mean (SD)

Estimated change over 24 months (SE)

Estimated difference ( P-value)

Systolic blood pressure (mmHg)

Intervention (n = 905)

145.9 (15.3)

139.6 (14.6)

-6.00 (0.46)

-4.76 (< 0.001)

Usual care (n = 927)

138.7 (13.5)

137.2 (12.6)

-1.24 (0.48)

Diastolic blood pressure (mmHg)

Intervention (n = 905)

83.7 (11.7)

80.2 (10.4)

-3.32 (0.38)

-1.88 (< 0.001)

Usual care (n = 927)

80.6 (9.2)

79.2 (8.0)

-1.44 (0.38)

LDL cholesterol (mmol/L)

Intervention (n = 905)

3.18 (1.03)

2.82 (0.85)

-0.31 (0.03)

0.05 (0.075)

Usual care (n = 927)

3.21 (1.03)

2.92 (0.91)

-0.26 (0.03)

MDRD-estimated GFR (ml/min)

Intervention (n = 905)

79.6 (19.6)

80.6 (20.1)

1.52 (0.48)

2.72 (< 0.001)

Usual care (n = 927)

80.8 (20.2)

78.9 (20.5)

-1.20 (0.48)

Framingham-Anderson Score (%)

Intervention (n = 905)

17.47

15.24

-2.23

0.06 (0.001)

Usual care (n = 927)

17.00

15.81

-1.19

Weight (kg)

Intervention (n = 905)

85.8 (16.5)

85.5 (16.8)

-0.28 (0.12)

-0.12 (0.470)

Usual care (n = 927)

85.6 (15.9)

85.4 (16.1)

-0.16 (0.12)

Waist circumference (cm)

Intervention (n = 905)

105.1 (12.8)

104.9 (13.3)

-0.08 (0.16)

-0.24 (0.269)

Usual care (n = 927)

105.1 (13.3)

105.3 (13.8)

0.16 (0.16)

HbA1c (%)

Intervention (n = 527)

7.01 (1.12)

7.03 (1.10)

0.03 (0.04)

0.01 (0.341)

 

Usual care (n = 521)

7.01 (1.23)

7.03 (1.13)

0.02 (0.04)

 
  1. LDL, low-density lipoprotein; MDRD-estimated GFR, MDRD-estimated glomerular filtration rate; SD, standard deviation; SE, standard error. P-values refer to the comparison of the changes between the intervention and usual care groups in a three-level hierarchical generalized linear model (see Statistics section).